Female sexual arousal disorder
ICD-10 F52.22 is a billable code used to indicate a diagnosis of female sexual arousal disorder.
Female sexual arousal disorder (FSAD) is characterized by a persistent or recurrent inability to attain or maintain adequate lubrication or swelling of the sexual organs during sexual activity, which causes marked distress or interpersonal difficulties. This condition can manifest in various ways, including a lack of sexual excitement, diminished sexual pleasure, or an inability to achieve orgasm. FSAD can be influenced by a multitude of factors, including psychological issues such as anxiety, depression, or past trauma, as well as physiological factors like hormonal imbalances, chronic illnesses, or side effects from medications. The disorder is often associated with other sexual dysfunctions, such as female orgasmic disorder or sexual pain disorders. Diagnosis typically involves a thorough medical history, physical examination, and possibly psychological evaluation to rule out other underlying conditions. Treatment options may include psychotherapy, hormonal therapy, or lifestyle changes aimed at improving sexual health and overall well-being.
Detailed psychological assessment and treatment history.
Patients presenting with anxiety or depression affecting sexual function.
Consideration of psychological therapies and their documentation.
Comprehensive gynecological history and physical examination findings.
Patients with hormonal imbalances or chronic pelvic pain.
Documentation of any hormonal treatments or interventions.
Used for patients undergoing therapy for sexual dysfunction.
Document the nature of the therapy and its relation to sexual dysfunction.
Psychiatrists should ensure that therapy goals are clearly defined.
Common causes include psychological factors such as anxiety and depression, hormonal changes, chronic illnesses, and certain medications. A thorough evaluation is necessary to identify the underlying causes.
